Tarsons Products Ltd Declines 3.23% Amid Bearish Momentum and 52-Week Low

4 hours ago
share
Share Via
Tarsons Products Ltd’s stock declined by 3.23% over the week ending 27 March 2026, closing at Rs.178.20, underperforming the Sensex which fell 1.46%. The week was marked by a fresh 52-week low on 23 March and persistent bearish technical signals, reflecting ongoing challenges for the micro-cap healthcare company amid broader market volatility.

Key Events This Week

23 Mar: New 52-week low at Rs.175

24 Mar: Bearish technical momentum confirmed

27 Mar: Week closes at Rs.178.20 (-3.23%)

Week Open
Rs.184.15
Week Close
Rs.178.20
-3.23%
Week High
Rs.184.15
vs Sensex
-1.77%

23 March 2026: Tarsons Hits New 52-Week Low Amid Continued Downtrend

On 23 March, Tarsons Products Ltd’s stock price plunged to a fresh 52-week low, touching an intraday bottom of Rs.175 before closing at Rs.177.60, down 3.56% for the day. This decline occurred despite the broader Sensex falling 3.13%, indicating the stock’s sharper underperformance. The day’s volume was 17,989 shares, reflecting active selling pressure.

The stock’s fall below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, confirmed a sustained bearish trend. This technical weakness was compounded by the company’s deteriorating financials, including a 40.41% decline in profit after tax over the latest six months and a low ROCE of 6.69%. Institutional investors further reduced their holdings by 3.44% in the previous quarter, now holding only 2.47% of shares, signalling waning confidence.

Tarsons’ one-year stock return of -45.60% starkly contrasts with the Sensex’s -5.04% over the same period, underscoring the company’s relative weakness. The stock’s micro-cap status and operating profit contraction at an annualised rate of 18.84% over five years add to the risk profile.

24 March 2026: Bearish Momentum Confirmed by Technical Indicators

Following the 52-week low, Tarsons Products Ltd’s stock rebounded modestly on 24 March, closing at Rs.182.85, up 2.96%. However, this short-term gain did not alter the prevailing bearish technical outlook. The stock remained below key moving averages, and Bollinger Bands on weekly and monthly charts continued to signal downward momentum.

Technical indicators presented a mixed picture: the weekly MACD and Know Sure Thing (KST) showed mild bullishness, but monthly readings remained bearish. The Relative Strength Index (RSI) hovered neutrally, indicating no oversold or overbought extremes. On-Balance Volume (OBV) suggested some accumulation, but this was insufficient to reverse the dominant downtrend.

The stock’s underperformance relative to the Sensex persisted, with Tarsons down 5.81% over the past week compared to the Sensex’s 3.72% decline. Year-to-date and longer-term returns also lagged significantly behind the benchmark, reflecting company-specific challenges amid a mixed sector environment.

Momentum building strong! This Mid Cap from NBFC is on our MomentumNow radar. Other investors are catching on – will you join?

  • - Building momentum strength
  • - Investor interest growing
  • - Limited time advantage

Join the Momentum →

27 March 2026: Week Ends with Further Decline Amid Market Volatility

On the final trading day of the week, Tarsons Products Ltd closed at Rs.178.20, down 3.23% from the previous Friday’s close of Rs.184.15. The stock’s decline outpaced the Sensex’s 1.46% fall over the same period, highlighting continued relative weakness. Volume increased to 13,165 shares, indicating sustained investor activity amid the downtrend.

Technical momentum remained bearish, with the stock trading below all major moving averages and monthly indicators confirming the negative trend. The absence of strong RSI signals suggests the stock is not yet oversold, implying potential for further downside before any meaningful recovery.

Despite mild weekly bullishness in some momentum indicators, the overall technical and fundamental outlook remains cautious. The company’s financial pressures, including declining profitability and reduced institutional participation, continue to weigh on investor sentiment.

Holding Tarsons Products Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!

  • - Peer comparison ready
  • - Superior options identified
  • - Cross market-cap analysis

Switch to Better Options →

Daily Price Performance: Tarsons Products Ltd vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-03-23 Rs.177.60 -3.56% 32,377.87 -3.13%
2026-03-24 Rs.182.85 +2.96% 33,009.57 +1.95%
2026-03-25 Rs.184.15 +0.71% 33,645.89 +1.93%
2026-03-27 Rs.178.20 -3.23% 32,935.19 -2.11%

Key Takeaways

Negative Signals: Tarsons Products Ltd’s stock hit a 52-week low at Rs.175 on 23 March, reflecting ongoing weakness. The stock closed the week down 3.23%, underperforming the Sensex’s 1.46% decline. Technical indicators confirm a bearish momentum with the stock trading below all major moving averages and monthly bearish signals dominating. Institutional investor holdings have declined, and financial metrics show contracting profitability and low returns on capital.

Positive Notes: Some weekly momentum indicators such as MACD and KST show mild bullishness, and On-Balance Volume suggests limited accumulation. The stock’s valuation metrics indicate a discount relative to peers, which may attract value-focused investors if conditions improve. The short-term bounce on 24 March demonstrated some resilience amid broader market volatility.

Conclusion

Tarsons Products Ltd experienced a challenging week marked by a fresh 52-week low and persistent bearish technical momentum. The stock’s 3.23% weekly decline outpaced the Sensex’s 1.46% fall, underscoring company-specific pressures amid a volatile market backdrop. While some short-term technical indicators hint at limited positive momentum, the dominant trend remains negative, supported by weak financial performance and reduced institutional interest. Investors should remain cautious and monitor for clear signs of trend reversal before considering exposure to this micro-cap healthcare stock.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News